Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-3-27
pubmed:abstractText
Interleukin (IL)-1 is an important mediator of inflammation and cardiovascular disease. Here, we examined the role of IL-1 in arterial neointima formation. Carotid artery neointima was induced by ligation, and arteries were harvested 4 weeks after injury. The neointima/media of mice deficient in the IL-1 signaling receptor (IL-1R1(-/-)) was significantly reduced compared to IL-1R1(+/+) controls (P < 0.01). IL-1R1(+/+) mice receiving subcutaneous IL-1ra also had significantly reduced neointima/media compared with placebo (P < 0.05). IL-1beta(-/-) mice had reduced neointima/media compared to wild-type (P < 0.05), whereas IL-1alpha(-/-) mice were no different from controls. Mice deficient in the P2X(7) receptor (involved in IL-1 release) or caspase-1 (involved in IL-1 activation) did not differ in their response to carotid ligation compared to controls. To examine the site of IL-1 signaling, we generated chimeric mice. IL-1R1(+/+) mice receiving IL-1R1(-/-) marrow and IL-1R1(-/-) mice receiving IL-1R1(+/+) marrow both had significantly reduced neointima/media compared with IL-1R1(+/+) to IL-1R1(+/+) (P < 0.05) but had significantly greater neointima/media than IL-1R1(-/-) to IL-1R1(-/-) controls (P < 0.05). These data confirm the importance of IL-1beta signaling in mediating arterial neointima formation and suggest the involvement of IL-1 signaling in both circulating and arterial wall cells. Furthermore, receptor antagonism may be a better therapeutic target than interruption of IL-1beta processing or release.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-10339575, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-10615399, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-11015350, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-11016935, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-11073843, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-11316947, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-11795265, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-11927948, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-12874179, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-1327576, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-15240711, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-15254086, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-1574116, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-16099441, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-1919436, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-2156847, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-2244864, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-2783498, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-3047139, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-3052359, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-3288634, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-3485687, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-3519678, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-7519205, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-7544359, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-7722467, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-7859282, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-8609234, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-8840858, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-8925587, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-9015751, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-9029121, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-9233643, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-9317135, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-9467064, http://linkedlifedata.com/resource/pubmed/commentcorrection/16565512-9565638
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
168
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1396-403
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice.
pubmed:affiliation
Cardiovascular Research Unit, University of Sheffield, Clinical Sciences Centre, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK. j.chamberlain@sheffield.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't